Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© 2014 SNL All rights reserved. Lactoferrin is a key component of the mammalian innate immune response. Infants born very preterm are relatively deficient in lactoferrin and may benefit from supplementation. Preliminary evidence suggests that bovine lactoferrin supplementation might prevent late-onset invasive infection and its associated mortality and morbidity. In the UK, the ELFIN Trial Investigators Group is undertaking a large, simple and pragmatic randomised controlled clinical trial to test this hypothesis.

Type

Journal article

Journal

Infant

Publication Date

01/09/2014

Volume

10

Pages

147 - 150